Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

PURPOSE: The 144-week results of the open-label, multicenter Atazanavir/Ritonavir Induction with Epzicom Study (ARIES) were stratified by gender to compare treatment responses. METHODS: A total of 369 HIV-infected, antiretroviral-naïve subjects receiving once-daily abacavir/lamivudine + atazanavir/r...

Descripción completa

Detalles Bibliográficos
Autores principales: Squires, Kathleen E, Young, Benjamin, Santiago, Lizette, Dretler, Robin H, Walmsley, Sharon L, Zhao, Henry H, Pakes, Gary E, Ross, Lisa L, Shaefer, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344433/
https://www.ncbi.nlm.nih.gov/pubmed/28424561
http://dx.doi.org/10.2147/HIV.S108756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344433/
https://www.ncbi.nlm.nih.gov/pubmed/28424561
http://dx.doi.org/10.2147/HIV.S108756

Ejemplares similares